The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
Ad26.ZEBOV
Ebola
MVA-BN-Filo
immunogenicity
malaria
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
02 Aug 2023
02 Aug 2023
Historique:
received:
01
07
2023
revised:
26
07
2023
accepted:
28
07
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
We assessed whether the immunogenicity of the two-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen with a 56-day interval between doses was affected by exposure to malaria before dose 1 vaccination and by clinical episodes of malaria in the period immediately after dose 1 and after dose 2 vaccinations. Previous malaria exposure in participants in an Ebola vaccine trial in Sierra Leone (ClinicalTrials.gov: NCT02509494) was classified as low, intermediate, and high according to their antibody responses to a panel of
Identifiants
pubmed: 37631885
pii: vaccines11081317
doi: 10.3390/vaccines11081317
pmc: PMC10459393
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT02509494']
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/S03286X/1
Pays : United Kingdom
Références
Clin Infect Dis. 2022 Oct 29;75(9):1585-1593
pubmed: 35640636
J Infect Dis. 2021 Dec 1;224(11):1907-1915
pubmed: 34013349
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
Lancet Infect Dis. 2022 Jan;22(1):97-109
pubmed: 34529963
Elife. 2015 May 08;4:
pubmed: 25955968
Ann Trop Med Parasitol. 1985 Dec;79(6):563-73
pubmed: 3834841
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4438-47
pubmed: 26216993
Pediatr Infect Dis J. 2000 May;19(5):444-9
pubmed: 10819341
Nat Commun. 2019 Oct 15;10(1):4531
pubmed: 31615986
Lancet. 2015 Aug 29;386(9996):857-66
pubmed: 26248676
Antiviral Res. 2018 Nov;159:63-67
pubmed: 30261226
Lancet. 2019 Nov 23;394(10212):1893
pubmed: 31777382
J Infect Dev Ctries. 2015 Feb 19;9(2):197-205
pubmed: 25699495
Emerg Infect Dis. 2022 Mar;28(3):734-738
pubmed: 35202536
Clin Infect Dis. 2020 Jun 10;70(12):2544-2552
pubmed: 31402382
PLoS One. 2022 Jul 6;17(7):e0270968
pubmed: 35793331